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Summary Visceral leishmaniasis (VL) is among the most neglected of the tropical diseases,
afﬂicting the poorest of the poor. In eastern Africa, VL causes at least 4000 deaths annually, a
loss of approximately 385 000 disability-adjusted life years. Due to the chronicity of underlyingSandﬂies;
Prevention;
Control;
Africa
causes, it is likely that the caseload will increase in the foreseeable future. While efforts should
be pursued to develop novel case management and prevention tools, several effective inter-
ventions already exist but are rarely deployed. Funds are needed now to procure commodities
and strengthen health systems, so that effective VL control can be delivered to populations at
risk.
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Visceral leishmaniasis (VL), or ‘kala-azar’, is a systemic
disease characterised by a range of symptoms includ-
ing fever, (hepato)splenomegaly, lymphadenopathy, weight
loss, weakness and, if left untreated, death (Murray et al.,
2005). VL is usually caused by Leishmania donovani or L.
infantum, protozoan parasites that are transmitted by phle-
botomine sandﬂies when feeding on the blood of human and
animal hosts. Eastern Africa is one of the world’s main VL-
endemic areas, and the disease occurs in numerous foci in
Eritrea, Ethiopia, Kenya, Somalia, Sudan and Uganda.The number of VL cases in the region has increased dra-
matically in the past decade. A major contributing factor
has been the ongoing armed conﬂicts, which have caused
widespread destruction of local housing and health infras-
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ructures, increasing people’s exposure to sandﬂy bites
nd making it hard to manage cases and deliver vector
ontrol activities. The conﬂicts have, in turn, induced mas-
ive movements of susceptible or infected populations into
L-endemic or non-endemic areas, respectively, triggering
ajor epidemics. Added to this ﬂux, sustained droughts
ave lead to widespread malnutrition and famine, two of
he main risk factors for VL. Conﬂict and drought probably
aused the largest VL epidemic ever recorded, during the
980s in Sudan, where VL killed an estimated 100 000 people
Seaman et al., 1996), a ﬁgure which may even be consid-
rably higher because of substantial under-reporting of VL
Collin et al., 2006). A ﬁnal factor contributing to the rise in
L cases in some populations is the increasing prevalence of
IV (Anema and Ritmeijer, 2005), another common risk fac-
or for VL (Murray et al., 2005). Because mass migration of
L-affected populations due to either armed conﬂict (e.g.
omalia) or peace (e.g. Sudan) will continue over the coming
ears, it is likely that the caseload will increase even further.
espite the signiﬁcant and increasing VL burden in eastern
lf of Royal Society of Tropical Medicine and Hygiene.
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frica, efforts to control the disease are either non-existent
r remain sub-optimal.
Few VL-endemic countries in eastern Africa have func-
ional leishmaniasis control programmes, and these have
ittle or no resources to train health staff on VL case manage-
ent and methods for prevention and control, let alone to
rocure commodities to implement activities. Many affected
eople thus have no access to VL diagnosis, treatment or
revention, and they die, undetected by the health informa-
ion system, in their community (Collin et al., 2006). Those
ases that receive VL treatment often do so only because of
emporary health service delivery provided by third party
rganisations (e.g. Me´de´cins Sans Frontie`res) or interna-
ional research projects (e.g. through the Leishmaniasis East
frican Platform of the Drugs for Neglected Diseases Initia-
ive). Moreover, owing to difﬁculties in accessing endemic
oci (e.g. because of security concerns or lack of infras-
ructure) up-to-date and scientiﬁcally credible data on the
pidemiology, disease burden and possible risk factors of VL
re scarce. The lack of such information adds to the difﬁ-
ulty of identifying and targeting populations at risk, and
electing appropriate tools for prevention and control.
However, several effective tools to diagnose, treat
r prevent VL have been developed and tested (Murray
t al., 2005), including: highly sensitive and speciﬁc
apid immunochromatographic dipsticks; effective and safe
eneric antimonial drugs; and long-lasting insecticidal nets
LLINs) for personal protection. Other tools have yet to be
ully developed, evaluated or operationalised, particularly
or eastern Africa; these include the use of geographic infor-
ation systems and remote sensing data to delineate VL risk
reas, and the use of drugs other than antimony to reduce
reatment duration, cost and toxicity and to delay antimony
rug resistance.
Rather than wait for the results from ongoing studies
n novel tools, the time has come to deploy the existing
nes. We advocate a strategy that combines commodity
upport (e.g. for dipsticks, drugs and LLINs), health system
trengthening, capacity building and operational research.
herever feasible, interventions should be integrated into
ultifunctional health service delivery in order to maximise
ffectiveness and resources. If substantial funds were made
vailable to provide this support, the reduction of the VL
urden would be highly cost-effective (Laxminarayan et al.,
006). Improved estimates of the number and location of
eople at risk are essential to determine and target inter-
ention resources required to control or even eliminate VL,
SR. Reithinger et al.
nd to lobby for the increased ﬁnancial and political sup-
ort to do so. Limited support is currently being provided
y WHO and, primarily, non-governmental organisations to
elp establish and support control programmes in Ethiopia,
enya and Sudan. There remains a need to expand these
fforts, ensuring a coordinated regional approach.
Past experience has shown that VL has a devastating
orbidity and mortality impact on affected communities.
everal tools to effectively prevent infection and manage
L exist; however, there has been a chronic lack of funds
o effectively implement them operationally. Making these
ools available at a greater scale, both locally and regionally,
ill lead to signiﬁcant inroads into the disease’s incidence
nd distribution.
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